Board of Directors
Dr. Anthony F. Holler
Dr. Iain Cleator
Todd Patrick
Ian Webb
Edward Wright
Dr. Anthony F. Holler, Chairman of the Board
Dr. Holler has served as one of our directors since December 2005. Dr. Holler was one of the original founders of ID Biomedical Corporation in 1991 and was a member of its Board of Directors since inception. He held a number of executive positions with ID Biomedical, including Chief Executive Officer, until the company was acquired by GlaxoSmithKline in December 2005. Prior to founding ID Biomedical, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia. He is a member of the British Columbia College of Physicians and Surgeons. Dr. Holler holds a Bachelor of Science degree and a medical degree from the University of British Columbia.
Member of: Audit Committee, Corporate Governance & Nominating Committee, Compensation CommitteeDr. Iain Cleator, Director
Iain Cleator, MB, ChB is Professor Emeritus of Surgery at the University of British Columbia. Dr. Cleator was first appointed to the Board of Directors of the Company on May 24, 2007 and he provides Medical Director services to the Company. He currently operates the Cleator Clinic, which he founded in 2003 to care for the many patients afflicted with anorectal disorders. Professor Cleator also founded the G.I. Clinic at St. Paul's hospital in Vancouver and held many positions there including Head of the G.I. Clinic and Head of Service. Dr. Cleator is a past President of the Canadian Association of Gastroenterologists as well as past President of the Vancouver Medical Association. A 1962 graduate in surgery from Edinburgh University, Dr. Cleator accepted a position as academic surgeon at the University of British Columbia in 1972. He is currently completing a three year term as Block Chair for the GI Teaching in second year Medical School.
Todd Patrick, Director
Mr. Patrick has served as one of our directors since May 2006. In 1999, Mr. Patrick was appointed President and Chief Operating Officer of ID Biomedical Corporation, a position he held until December 2005 when GlaxoSmithKline acquired the company. Mr. Patrick originally joined ID Biomedical in 1994 as the President of its then newly–created vaccine subsidiary, ID Vaccine. Prior to joining ID Biomedical, Mr. Patrick was employed by the University of California, Los Angeles (UCLA) as the Director of the Office of Intellectual Property Administration, where he was responsible for the patenting and licensing of intellectual property arising out of UCLA. Mr. Patrick holds a Bachelor of Economics degree from the University of Washington and a Masters in Business Administration from Washington State University.
Member of: Audit Committee, Corporate Governance & Nominating Committee, Compensation CommitteeIan Webb, Director
Mr. Webb has served as one of our directors since May 2006. He is a partner at the Vancouver offices of Borden Ladner Gervais LLP. Mr. Webb was admitted to the British Columbia bar in 1982. He is a graduate of Osgoode Hall Law School at York University with a Bachelor of Laws in 1981. Prior to that, he received a Master of Science in Theoretical Physics from the University of Saskatchewan in 1976. Mr. Webb practices in the areas of corporate and securities law with an emphasis on the legal requirements of public companies.
Member of: Audit Committee, Corporate Governance & Nominating CommitteeEdward Wright, Chief Executive Officer, President and Director
Mr. Wright has extensive management and leadership experience in the luxury retail and wholesale sectors. His background includes considerable success in developing and operating the North American divisions of some of the world’s leading luxury brands.
Mr. Wright, until 2006 was the Executive Vice President of Retail in North America for Cartier, a top international luxury brand with a storied history dating back to the 1800’s. Prior to Cartier, Mr. Wright held the position of President of Baume & Mercier since 2002. While at Cartier, Mr. Wright was responsible for the development and operations of the entire North American retail division including implementation of strategic goals, supervision of retail development, and ensuring successful attainment of Cartier’s retail objectives for the North American market segment. Upon returning to Vancouver, B.C., Mr. Wright became the Chief Executive Officer of CRH Medical, a fast growing North American medical company.
Previous: Business Model Next: Medical Advisory Board 